These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 30355136)
1. Established and Emerging Roles of Biomarkers in Heart Failure. Ibrahim NE; Januzzi JL Circ Res; 2018 Aug; 123(5):614-629. PubMed ID: 30355136 [TBL] [Abstract][Full Text] [Related]
2. Beyond Natriuretic Peptides for Diagnosis and Management of Heart Failure. Ibrahim NE; Januzzi JL Clin Chem; 2017 Jan; 63(1):211-222. PubMed ID: 28062619 [TBL] [Abstract][Full Text] [Related]
3. Novel Biomarkers in Heart Failure: New Insight in Pathophysiology and Clinical Perspective. Biasucci LM; Maino A; Grimaldi MC; Cappannoli L; Aspromonte N J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34202603 [TBL] [Abstract][Full Text] [Related]
4. The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management. Ibrahim N; Januzzi JL Expert Rev Cardiovasc Ther; 2015; 13(9):1017-30. PubMed ID: 26198476 [TBL] [Abstract][Full Text] [Related]
5. Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association. Chow SL; Maisel AS; Anand I; Bozkurt B; de Boer RA; Felker GM; Fonarow GC; Greenberg B; Januzzi JL; Kiernan MS; Liu PP; Wang TJ; Yancy CW; Zile MR; Circulation; 2017 May; 135(22):e1054-e1091. PubMed ID: 28446515 [TBL] [Abstract][Full Text] [Related]
6. Beyond Natriuretic Peptides: Unveiling the Power of Emerging Biomarkers in Heart Failure. Licordari R; Correale M; Bonanno S; Beltrami M; Ciccarelli M; Micari A; Palazzuoli A; Dattilo G Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540729 [TBL] [Abstract][Full Text] [Related]
7. Biomarkers: Their potential in the diagnosis and treatment of heart failure. Heil B; Tang WH Cleve Clin J Med; 2015 Dec; 82(12 Suppl 2):S28-35. PubMed ID: 26694889 [TBL] [Abstract][Full Text] [Related]
8. [Expert consensus on the usefulness of natriuretic peptides in heart failure.]. Nessler J; Straburzyńska-Migaj E; Windak A; Solnica B; Szmitkowski M; Paradowski M; Kaźmierczak J; Puacz E; Rozentryt P Kardiol Pol; 2018; 76(1):215-224. PubMed ID: 29399772 [TBL] [Abstract][Full Text] [Related]
9. Biomarkers in heart failure: a focus on natriuretic peptides. Eltayeb M; Squire I; Sze S Heart; 2024 May; 110(11):809-818. PubMed ID: 37673654 [TBL] [Abstract][Full Text] [Related]
10. The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study. Ibrahim NE; Januzzi JL Curr Heart Fail Rep; 2018 Apr; 15(2):37-43. PubMed ID: 29468530 [TBL] [Abstract][Full Text] [Related]
11. Multimarker testing with ST2 in chronic heart failure. Bayes-Genis A; Richards AM; Maisel AS; Mueller C; Ky B Am J Cardiol; 2015 Apr; 115(7 Suppl):76B-80B. PubMed ID: 25697916 [TBL] [Abstract][Full Text] [Related]
15. The role of natriuretic peptides as biomarkers for guiding the management of chronic heart failure. Motiwala SR; Januzzi JL Clin Pharmacol Ther; 2013 Jan; 93(1):57-67. PubMed ID: 23187878 [TBL] [Abstract][Full Text] [Related]